TORONTO, Nov. 29, 2024 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today its financial results for the three and nine months ended September 30, 2024. The Company will host a conference call to discuss its financial and business highlights on November 29, 2024, at 10 a.m. Eastern Time.
GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Latest posts by GlobeNewswire (see all)
- Voxtur Announces Amendments to Financial Statements and MD&A for Q3 Ended September 30, 2024 - December 6, 2024
- Brazilian Court Confirms Tenaris’s Obligation to Pay Indemnification in connection with its 2012 Acquisition of a Participation in Usiminas; the Decision is subject to Further Appeals - December 6, 2024
- Tandy Leather Factory Announces Agreement to Sell Headquarters Facilities - December 6, 2024
